Provided by Tiger Trade Technology Pte. Ltd.

Vanda Pharmaceuticals

7.25
+0.43006.30%
Post-market: 7.21-0.0400-0.55%19:48 EDT
Volume:1.26M
Turnover:8.99M
Market Cap:428.45M
PE:-1.94
High:7.27
Open:6.92
Low:6.91
Close:6.82
52wk High:9.94
52wk Low:3.81
Shares:59.10M
Float Shares:49.48M
Volume Ratio:0.34
T/O Rate:2.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7413
EPS(LYR):-3.7413
ROE:-50.93%
ROA:-16.50%
PB:1.31
PE(LYR):-1.94

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Silver miners, Jefferies, Vanda

Reuters
·
Nov 28, 2025

BRIEF-Vanda Pharmaceuticals Provides Regulatory Update On Tradipitant For Motion Sickness

Reuters
·
Nov 28, 2025

Vanda Pharmaceuticals' Motion Sickness Drug Tradipitant Advances in FDA Regulatory Review

Reuters
·
Nov 28, 2025

Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness

THOMSON REUTERS
·
Nov 28, 2025

Vanda Pharmaceuticals Inc - FDA Extends Re-Review of Partial Clinical Hold to Dec 5, 2025

THOMSON REUTERS
·
Nov 28, 2025

Vanda Pharmaceuticals Leads 3 Promising Penny Stocks

Simply Wall St.
·
Nov 21, 2025

Vanda Pharmaceuticals (VNDA): Valuation Focus After Positive Tradipitant Trial Results and Regulatory Progress

Simply Wall St.
·
Nov 20, 2025

Vanda Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
Nov 19, 2025

H.C. Wainwright Sticks to Their Buy Rating for Vanda (VNDA)

TIPRANKS
·
Nov 19, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Energizer Holdings, Target

Reuters
·
Nov 19, 2025

Vanda Pharmaceuticals Up Nearly 20%, on Pace for Largest Percent Increase Since June 2024 -- Data Talk

Dow Jones
·
Nov 19, 2025

Side Effects From Wegovy? This Vanda Pharmaceuticals' Drug Halves Vomiting In Patients

Benzinga
·
Nov 18, 2025

Vanda Pharmaceuticals Shares up 7.1% After Nausea Drug Shows Promise for Glp-1 Side Effects

THOMSON REUTERS
·
Nov 18, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Cloudflare, Legence, Lumentum

Reuters
·
Nov 18, 2025

BUZZ-Vanda rises as nausea drug shows promise for GLP-1 side effects

Reuters
·
Nov 18, 2025

Vanda Pharmaceuticals Shares up 7% Premarket After Reporting Positive Results for Tradipitant in Preventing Glp-1 Induced Nausea and Vomiting

THOMSON REUTERS
·
Nov 18, 2025

Vanda Pharmaceuticals’ tradipitant shows positive results in nausea, vomiting

TIPRANKS
·
Nov 18, 2025

BRIEF-Vanda Pharmaceuticals Reports Positive Results For Tradipitant In Preventing Glp-1 Induced Nausea And Vomiting

Reuters
·
Nov 18, 2025

Vanda Pharmaceuticals Reports Positive Trial Results for Tradipitant in Preventing GLP-1 Agonist-Induced Nausea

Reuters
·
Nov 18, 2025

Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing Glp-1 Induced Nausea and Vomiting

THOMSON REUTERS
·
Nov 18, 2025